The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Aminah Jatoi

Mayo Clinic

200 First Street

SW, Rochester

MN, 55905

USA

[email]@mayo.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA. 2001 - 2011
  • Department of Oncology, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA. 2010
  • Department of Medicine, The New England Medical Center, Tufts University, Boston, USA. 1999 - 2001

References

  1. Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB). Jatoi, A., Dakhil, S.R., Sloan, J.A., Kugler, J.W., Rowland, K.M., Schaefer, P.L., Novotny, P.J., Wender, D.B., Gross, H.M., Loprinzi, C.L. Support. Care. Cancer (2011) [Pubmed]
  2. Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors. Jatoi, A., Soori, G., Foster, N.R., Hiatt, B.K., Knost, J.A., Fitch, T.R., Callister, M.D., Nichols, F.C., Husted, T.M., Alberts, S.R. J. Thorac. Oncol (2010) [Pubmed]
  3. A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422). Jatoi, A., Schild, S.E., Foster, N., Henning, G.T., Dornfeld, K.J., Flynn, P.J., Fitch, T.R., Dakhil, S.R., Rowland, K.M., Stella, P.J., Soori, G.S., Adjei, A.A. Ann. Oncol. (2010) [Pubmed]
  4. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Jatoi, A., Foster, N.R., Egner, J.R., Burch, P.A., Stella, P.J., Rubin, J., Dakhil, S.R., Sargent, D.J., Murphy, B.R., Alberts, S.R. Int. J. Oncol. (2010) [Pubmed]
  5. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Jatoi, A., Ritter, H.L., Dueck, A., Nguyen, P.L., Nikcevich, D.A., Luyun, R.F., Mattar, B.I., Loprinzi, C.L. Lung. Cancer (2010) [Pubmed]
  6. The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Jatoi, A., Qi, Y., Kendall, G., Jiang, R., McNallan, S., Cunningham, J., Mandrekar, S., Yang, P. Support. Care. Cancer (2010) [Pubmed]
  7. Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4). Jatoi, A., Thrower, A., Sloan, J.A., Flynn, P.J., Wentworth-Hartung, N.L., Dakhil, S.R., Mattar, B.I., Nikcevich, D.A., Novotny, P., Sekulic, A., Loprinzi, C.L. Oncologist (2010) [Pubmed]
  8. Cancer chemotherapy: with or without food?. Jatoi, A. Support. Care. Cancer (2009) [Pubmed]
  9. Bisphosphonates: preventing skeletal morbidity and maybe doing more. Jatoi, A. Curr. Oncol. Rep (2009) [Pubmed]
  10. Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147. Jatoi, A., Green, E.M., Rowland, K.M., Sargent, D.J., Alberts, S.R. Oncology (2009) [Pubmed]
  11. Palliating hiccups in cancer patients: moving beyond recommendations from Leonard the lion. Jatoi, A. J. Support. Oncol (2009) [Pubmed]
  12. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Jatoi, A., Rowland, K., Sloan, J.A., Gross, H.M., Fishkin, P.A., Kahanic, S.P., Novotny, P.J., Schaefer, P.L., Johnson, D.B., Tschetter, L.K., Loprinzi, C.L. Cancer (2008) [Pubmed]
  13. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). Jatoi, A., Dakhil, S.R., Foster, N.R., Ma, C., Rowland, K.M., Moore, D.F., Jaslowski, A.J., Thomas, S.P., Hauge, M.D., Flynn, P.J., Stella, P.J., Alberts, S.R. J. Thorac. Oncol (2008) [Pubmed]
  14. Rash from EGFR inhibitors: opportunities and challenges for palliation. Solomon, B.M., Jatoi, A. Curr. Oncol. Rep (2008) [Pubmed]
  15. Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy. Jatoi, A., Nguyen, P.L. Oncologist (2008) [Pubmed]
  16. Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials. Jatoi, A., Nguyen, P.L. Expert. Opin. Investig. Drugs (2008) [Pubmed]
  17. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Jatoi, A., Dakhil, S.R., Nguyen, P.L., Sloan, J.A., Kugler, J.W., Rowland, K.M., Soori, G.S., Wender, D.B., Fitch, T.R., Novotny, P.J., Loprinzi, C.L. Cancer (2007) [Pubmed]
  18. Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Jatoi, A., Martenson, J.A., Foster, N.R., McLeod, H.L., Lair, B.S., Nichols, F., Tschetter, L.K., Moore, D.F., Fitch, T.R., Alberts, S.R. Am. J. Clin. Oncol. (2007) [Pubmed]
  19. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. Jatoi, A., Nguyen, P.L., Foster, N., Sun, D., Stella, P.J., Campbell, M., Tschetter, L.K., Dakhil, S.R., Mailliard, J.A., Nikcevich, D.A. J. Support. Oncol (2007) [Pubmed]
  20. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Jatoi, A., Burch, P., Hillman, D., Vanyo, J.M., Dakhil, S., Nikcevich, D., Rowland, K., Morton, R., Flynn, P.J., Young, C., Tan, W. Urology (2007) [Pubmed]
  21. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort. Jatoi, A., Novotny, P., Cassivi, S., Clark, M.M., Midthun, D., Patten, C.A., Sloan, J., Yang, P. Oncologist (2007) [Pubmed]
  22. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Jatoi, A., Murphy, B.R., Foster, N.R., Nikcevich, D.A., Alberts, S.R., Knost, J.A., Fitch, T.R., Rowland, K.M. Ann. Oncol. (2006) [Pubmed]
  23. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer. Jatoi, A., Foster, N., Wieland, B., Murphy, B., Nikcevich, D., LaPlant, B., Palcic, M.M., Baracos, V. Dis. Esophagus (2006) [Pubmed]
  24. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach. Jatoi, A. J. Support. Oncol (2006) [Pubmed]
  25. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Jatoi, A., Kahanic, S.P., Frytak, S., Schaefer, P., Foote, R.L., Sloan, J., Petersen, R.C. Support. Care. Cancer (2005) [Pubmed]
  26. Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: results from the Mayo Clinic lung cancer cohort. Jatoi, A., Williams, B.A., Marks, R., Nichols, F.C., Aubry, M.C., Wampfler, J., Yang, P. Nutr. Cancer (2005) [Pubmed]
  27. Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group. Jatoi, A., Alberts, S.R., Foster, N., Morton, R., Burch, P., Block, M., Nguyen, P.L., Kugler, J. Support. Care. Cancer (2005) [Pubmed]
  28. Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome?. Jatoi, A. Crit. Rev. Oncol. Hematol. (2005) [Pubmed]
  29. Omega-3 fatty acid supplements for cancer-associated weight loss. Jatoi, A. Nutr. Clin. Pract (2005) [Pubmed]
  30. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. Jatoi, A., Hillman, S., Stella, P., Green, E., Adjei, A., Nair, S., Perez, E., Amin, B., Schild, S.E., Castillo, R., Jett, J.R. J. Clin. Oncol. (2005) [Pubmed]
  31. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. Jatoi, A., Rowland, K., Loprinzi, C.L., Sloan, J.A., Dakhil, S.R., MacDonald, N., Gagnon, B., Novotny, P.J., Mailliard, J.A., Bushey, T.I., Nair, S., Christensen, B. J. Clin. Oncol. (2004) [Pubmed]
  32. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Jatoi, A., Egner, J., Loprinzi, C.L., Sloan, J.A., Novotny, P.J., Dakhil, S.R., Mailliard, J.A., Klee, G.G., Krook, J.E. Support. Care. Cancer (2004) [Pubmed]
  33. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. Jatoi, A., Podratz, K.C., Gill, P., Hartmann, L.C. J. Support. Oncol (2004) [Pubmed]
  34. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Jatoi, A., Jett, J.R., Sloan, J., Novotny, P., Ford, J., Prabhakar, U., Loprinzi, C.L. Support. Care. Cancer (2004) [Pubmed]
  35. Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group. Jatoi, A., Martenson, J., Mahoney, M.R., Lair, B.S., Brindle, J.S., Nichols, F., Caron, N., Rowland, K., Tschetter, L., Alberts, S. Int. Semin. Surg. Oncol (2004) [Pubmed]
  36. Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group. Jatoi, A., Foster, N., Johnson, P., Klee, G., Quevedo, J.F., Morton, R.F., Nair, S., Kardinal, C.G., Mailliard, J.A. Dis. Esophagus (2004) [Pubmed]
  37. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Jatoi, A., Ellison, N., Burch, P.A., Sloan, J.A., Dakhil, S.R., Novotny, P., Tan, W., Fitch, T.R., Rowland, K.M., Young, C.Y., Flynn, P.J. Cancer (2003) [Pubmed]
  38. Why should we care about the cancer anorexia/weight loss syndrome?. Jatoi, A. Oncology (Williston Park, N.Y.) (2003) [Pubmed]
  39. A phase II study of topical ceramides for cutaneous breast cancer. Jatoi, A., Suman, V.J., Schaefer, P., Block, M., Loprinzi, C., Roche, P., Garneau, S., Morton, R., Stella, P.J., Alberts, S.R., Pittelkow, M., Sloan, J., Pagano, R. Breast Cancer Res. Treat. (2003) [Pubmed]
  40. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Jatoi, A., Hillman, S., Stella, P.J., Mailliard, J.A., Sloan, J., Vanone, S., Cannon, M.W., Kutteh, L., Kanard, A., Jett, J.R. Support. Care. Cancer (2003) [Pubmed]
  41. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Jatoi, A., Yamashita, J., Sloan, J.A., Novotny, P.J., Windschitl, H.E., Loprinzi, C.L. Support. Care. Cancer (2002) [Pubmed]
  42. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. Jatoi, A., Windschitl, H.E., Loprinzi, C.L., Sloan, J.A., Dakhil, S.R., Mailliard, J.A., Pundaleeka, S., Kardinal, C.G., Fitch, T.R., Krook, J.E., Novotny, P.J., Christensen, B. J. Clin. Oncol. (2002) [Pubmed]
  43. A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia. Jatoi, A., Tirona, M.T., Cha, S.S., Alberts, S.R., Rowland, K.M., Morton, R.F., Nair, S., Kardinal, C.G., Stella, P.J., Mailliard, J.A., Sargen, D., Goldberg, R.M. Int. J. Gastrointest. Cancer (2002) [Pubmed]
  44. Folate status among patients with non-small cell lung cancer: a case-control study. Jatoi, A., Daly, B.D., Kramer, G., Mason, J.B. J. Surg. Oncol (2001) [Pubmed]
  45. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Jatoi, A., Loprinzi, C.L., Sloan, J.A., Klee, G.G., Windschitl, H.E. Cancer (2001) [Pubmed]
  46. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?. Jatoi, A., Daly, B.D., Hughes, V.A., Dallal, G.E., Kehayias, J., Roubenoff, R. Ann. Thorac. Surg. (2001) [Pubmed]
  47. The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer. Jatoi, A., Daly, B.D., Hughes, V., Dallal, G.E., Roubenoff, R. Lung. Cancer (1999) [Pubmed]
 
WikiGenes - Universities